Concurrently, assessing the ubiquitination levels of ACSL4 in prostate cancer cells, we ascertained that SKP2’s overexpression markedly amplified ACSL4 ubiquitination in a dose-correlated manner (Fig. 4H). The gene discussed is SKP2; the disease is prostate carcinoma.